ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of ...
Your donation today will help MinnPost continue to report on the news you need. Five years ago, Nancy Skoog-Edholm had no idea that she had two brain aneurysms. Then she started feeling sick. “I had a ...
Terumo Corporation’s (TRUMY) wholly-owned subsidiary MicroVention, Inc. recently announced the publication of the Clinical Evaluation of WEB 17 Device in Intracranial Aneurysms (CLEVER) study results.
A braided wire device known as the Woven EndoBridge (WEB) was developed to overcome those limitations. The device is placed inside the aneurysm under angiographic guidance, where it causes a clot to ...
A prospective multicenter study reports that Woven EndoBridge intrasaccular therapy safely and effectively treats unruptured ...
SAN DIEGO & ALISO VIEJO, Calif.--(BUSINESS WIRE)--MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, announced the publication of WEB-IT 5-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results